Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: dys1 / Correction greeneyes
1
Nov 09, 2007 10:38AM

Nov 09, 2007 10:57AM
4
Nov 11, 2007 01:58AM
2
Nov 11, 2007 03:30AM
4
Nov 11, 2007 09:28AM

Nov 11, 2007 10:19AM
3
Nov 12, 2007 06:54AM

Nov 12, 2007 09:34AM
Rigoli's statement that "the companies were continuing discussion on the claims" leads me to rule out the USPTO action as the reason, as if the re-exam decision was the reason, why would the companies continue to discuss the claims.  Either they'd proceed on the course to trial, OR, they'd halt discussions pending the decision as presumably it would be a defining issue one way or the other (defining enough to warrant a stay).  Perhaps wanting to see what I see, but seems logical to me.
3
Nov 12, 2007 09:43AM

Nov 12, 2007 10:28AM
Share
New Message
Please login to post a reply